General Information of This Metabolic Reaction (MR) (ID: MR012800)
Formula Reactant UK-453,061 Metabolite M21 Product UK-453,061 Metabolite M9
Reactant Info Product Info
Metabolic Type Multi-steps Reaction - N-dealkylation; glucuronidation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012796 UK-453,061 UK-453,061 Metabolite M21 Unclear UK-453,061 [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012797 UK-453,061 Metabolite M21 UK-453,061 Metabolite M16 Unclear UK-453,061 [1]
MR012799 UK-453,061 Metabolite M21 UK-453,061 Metabolite M2 Multi-steps Reaction - Glucuronidation; N-dealkylation; mono-oxidation UK-453,061 [1]
MR012798 UK-453,061 Metabolite M21 UK-453,061 Metabolite M22 Unclear UK-453,061 [1]
References
1 Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [14C]Lersivirine to healthy volunteers. Drug Metab Dispos. 2010 May;38(5):789-800.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.